Exponent (NASDAQ:EXPO) CEO Sells $226,727.64 in Stock

Exponent, Inc. (NASDAQ:EXPO) CEO Catherine Corrigan sold 4,194 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.06, for a total value of $226,727.64. Following the completion of the sale, the chief executive officer owned 105,218 shares in the company, valued at $5,688,085.08. This represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Catherine Corrigan also recently made the following trade(s):

• On Monday, March 16th, Catherine Corrigan sold 3,912 shares of Exponent stock. The shares were sold at an average price of $67.49, for a total value of $264,020.88.
• On Wednesday, April 15th, Catherine Corrigan sold 3,909 shares of Exponent stock. The shares were sold at an average price of $67.70, for a total value of $264,639.30.
• On Tuesday, February 17th, Catherine Corrigan sold 3,920 shares of Exponent stock. The shares were sold at an average price of $67.15, for a total value of $263,228.00.

Exponent Trading Up 0.2%

Shares of NASDAQ:EXPO traded up $0.12 on Friday, hitting $53.79. The company had a trading volume of 664,262 shares, compared to its average volume of 499,505. Exponent, Inc. has a 52-week low of $51.91 and a 52-week high of $81.95. The business has a 50 day moving average of $65.71 and a 200 day moving average of $69.74. The company has a market cap of $2.61 billion, a PE ratio of 25.02 and a beta of 0.78.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, April 30th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. Exponent had a return on equity of 27.94% and a net margin of 18.07%.The business had revenue of $166.30 million for the quarter, compared to the consensus estimate of $149.53 million. During the same period in the prior year, the business earned $0.52 earnings per share. The business’s revenue was up 14.3% on a year-over-year basis. As a group, equities analysts predict that Exponent, Inc. will post 2.28 EPS for the current year.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Friday, June 5th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, June 5th. Exponent’s dividend payout ratio is presently 57.67%.

Institutional Investors Weigh In On Exponent

Several institutional investors have recently bought and sold shares of EXPO. Bell Investment Advisors Inc grew its stake in Exponent by 423.6% during the first quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock worth $25,000 after buying an additional 305 shares during the period. Hantz Financial Services Inc. grew its stake in Exponent by 97.0% during the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after buying an additional 195 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in shares of Exponent in the third quarter valued at about $33,000. Allworth Financial LP grew its stake in shares of Exponent by 86.1% in the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock valued at $33,000 after buying an additional 217 shares in the last quarter. Finally, Winnow Wealth LLC acquired a new stake in shares of Exponent in the third quarter valued at about $34,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EXPO has been the subject of several analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research note on Tuesday, April 21st. UBS Group dropped their target price on Exponent from $85.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, JPMorgan Chase & Co. dropped their target price on Exponent from $95.00 to $80.00 and set an “overweight” rating for the company in a research note on Friday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $77.50.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.